Lumei Liu

Lumei Liu

Auto-generated profile, based on publicly available information

Lumei Liu

College of Integrated Chinese and Western Medicine, Hunan Provincial Key Laboratory for Prevention and Treatment of Heart and Brain Diseases with Integrated Traditional Chinese and Western Medicine, Hunan University of Traditional Chinese Medicine, Hunan, 410208, China

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2017 in RNA Biology
Verified
Journal Article
Open access
LLLumei Liu
Lumei Liu
JWJian Wang
Jian Wang
RKRamin Khanabdali
Ramin Khanabdali
BKBill Kalionis
Bill Kalionis
XTXiantao Tai
Xiantao Tai
SXShijin Xia
Shijin Xia
Circular RNA (circRNA) generated by alternative splicing represents a special class of non-coding RNA molecule. CircRNAs are abundant in the eukaryotic cell cytoplasm and have a characteristic organization, timing of action and disease specificity. In contrast to linear RNA, circRNAs are resistant to RNA exonuclease. Consequently, circRNA escapes normal RNA turnover and this improves circRNA stability. CircRNAs can be degraded by microRNA (miRNA) and this results in linearization of the circRNA, which can then act as competitor to endogenous RNA. Through interactions with disease-related miRNA, circRNA can play an important regulatory role in specific diseases. Furthermore, circRNAs have significant potential to become new clinical diagnostic markers.

1 September 2014 in Neurochemistry International
Verified
Journal Article
Closed access
LLLumei Liu
Lumei Liu
WWWenbin Wan
Wenbin Wan
SXShijin Xia
Shijin Xia
BKBill Kalionis
Bill Kalionis
YLYaming Li
Yaming Li

1 January 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
WWWenbin Wan
Wenbin Wan
SXShijin Xia
Shijin Xia
BKBill Kalionis
Bill Kalionis
LLLumei Liu
Lumei Liu
YLYaming Li
Yaming Li
Accumulating evidence supports a key role for Wnt signaling in the development of the central nervous system (CNS) during embryonic development and in the regulation of the structure and function of the adult brain. Alzheimer’s disease (AD) is the most common form of senile dementia, which is characterized byβ-amyloid (Aβ) deposition in specific brain regions. However, the molecular mechanism underlying AD pathology remains elusive. Dysfunctional Wnt signaling is associated with several diseases such as epilepsy, cancer, metabolic disease, and AD. Increasing evidence suggests that downregulation of Wnt signaling, induced by Aβ, is associated with disease progression of AD. More importantly, persistent activation of Wnt signaling through Wnt ligands, or inhibition of negative regulators of Wnt signaling, such as Dickkopf-1 (DKK-1) and glycogen synthase kinase-3β(GSK-3β) that are hyperactive in the disease state, is able to protect against Aβtoxicity and ameliorate cognitive performance in AD. Together, these data suggest that Wnt signaling might be a potential therapeutic target of AD. Here, we review recent studies related to the progression of AD where Wnt signaling might be relevant and participate in the development of the disease. Then, we focus on the potential relevance of manipulating the Wnt signaling pathway for the treatment of AD.

1 March 2019 in International Immunopharmacology
Verified
Journal Article
Closed access
LLLumei Liu
Lumei Liu
ZZZhengxiao Zhao
Zhengxiao Zhao
LLLinwei Lu
Linwei Lu
JLJiaqi Liu
Jiaqi Liu
JSJing Sun
Jing Sun
JDJingcheng Dong
Jingcheng Dong

1 October 2019 in International Immunopharmacology
Verified
Journal Article
Closed access
LLLumei Liu
Lumei Liu
ZZZhengxiao Zhao
Zhengxiao Zhao
LLLinwei Lu
Linwei Lu
JLJiaqi Liu
Jiaqi Liu
JSJing Sun
Jing Sun
JDJingcheng Dong
Jingcheng Dong

23 February 2024 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
XFXinying Fu
Xinying Fu
SYSiyang Yan
Siyang Yan
ZHZongren Hu
Zongren Hu
WSWen Sheng
Wen Sheng
WLWanyu Li
Wanyu Li
QHQinghu He
Qinghu He